The global pediatric perfusion products market is projected to reach USD 640.2 million in 2025, driven by the increasing prevalence of congenital heart defects (CHD) and pediatric cardiovascular diseases. As the demand for advanced cardiac care solutions grows, market expansion is expected, with sales forecasted to reach USD 989.98 million by 2033. With a Compound Annual Growth Rate (CAGR) of 5.60% from 2025 to 2033, the market is set for steady growth. Key drivers include technological advancements in perfusion systems, rising pediatric surgical procedures, and increasing awareness of early diagnosis and treatment options for congenital heart conditions.